The first legal shipment to the United States of an extract with a high content of THC, the main psychoactive cannabinoid derived from cannabis and a controlled substance under international treaties, was made from Colombia, which will be used for scientific research to analyze the composition and safety of cannabis in the form of steam.
The controlled substance was cultivated and extracted at the NatuEra company’s facilities, located in the Bogotá savannah, and was exported with the authorization of the National Narcotics Fund and imported into the United States under a permit from the DEA.
According to Nicolas Nannetti, CEO of NatuEra, this submission will serve to guide the public policy discussions that are advancing on the legalization of cannabis at the federal level in the United States through a responsible and science-based regulatory framework.
He said this is a significant milestone at a time when the pharmaceutical industry, mass consumption and academia seek to advance the research required to guide the public policy discussions that are underway on the legalization and regulation of cannabis at the federal level.
At present, cannabis for medicinal purposes has been legalized in some form in 36 of the 50 states of the United States of America. However, content greater than 0.3% THC or so-called psychoactive cannabis is still a controlled substance in the United States under the more restrictive category of the Controlled Substances Act of 1970, which is reserved for those drugs without uses. accepted physicians who have a high potential for abuse, Nannetti explained.
In December 2020, the United Nations Commission on Narcotic Drugs, in a landmark decision, accepted the recommendation of the World Health Organization (WHO) to remove cannabis from the most restrictive list of controlled substances, recognizing its importance and useful for medical and scientific purposes for the first time.